Chronic cocaine use is associated with disrupted dopaminergic neurotransmission but how this disruption affects overall brain function (other than reward/motivation) is yet to be fully investigated. Here we test the hypothesis that cocaine addicted subjects will have disrupted functional connectivity between the midbrain (where dopamine neurons are located) and cortical and subcortical brain regions during the performance of a sustained attention task.
We measured brain activation and functional connectivity with fMRI in 20 cocaine abusers and 20 matched controls. When compared to controls, cocaine abusers had lower positive functional connectivity of midbrain with thalamus, cerebellum, and rostral cingulate, and this was associated with decreased activation in thalamus and cerebellum and enhanced deactivation in rostral cingulate.
These findings suggest that decreased functional connectivity of the midbrain interferes with the activation and deactivation signals associated with sustained attention in cocaine addicts.
Citation: Tomasi D, Volkow ND, Wang R, Carrillo JH, Maloney T, et al. (2010) Disrupted Functional Connectivity with Dopaminergic Midbrain in Cocaine Abusers. PLoS ONE 5(5): e10815. doi:10.1371/journal.pone.0010815
Editor: Pedro Antonio Valdes-Sosa, Cuban Neuroscience Center, Cuba
Received: January 19, 2010; Accepted: May 3, 2010; Published: May 25, 2010
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: U.S. Department of Energy (Office of Biological and Environmental Research), the National Institutes of Health (GCRC 5-MO1-RR-10710), the National Institute on Alcohol Abuse and Alcoholism (2RO1AA09481, R01AA09481 and Y1AA3009) and the National Institute on Drug Abuse (1R01DA023579 and R21DA02062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
With repeated use, cocaine leads to neuroadaptations in dopaminergic function (as well as neuroadaptations in other catecholamines and glutamatergic and gabaergic systems) –. These neuroadaptations could interfere with the functional connectivity of brain regions modulated by dopamine and thus contribute to the decreased reward sensitivity, enhanced stress reactivity, and executive cognitive dysfunction reported in cocaine abusers , –.
The fluctuations of neural activity that mediate neuroadaptations  can alter dynamically the cerebral blood flow and volume  and produce synchronous magnetic resonance imaging (MRI) signals in different brain regions . This synchronous MRI signal fluctuations have been used to assess the in-vivo functional connectivity of the human brain in resting-state conditions . Here we studied the correlation between signals in midbrain, which is where dopamine (DA) neurons are located, and those in cortical and subcortical structures during sustained attention conditions as a way to assess the modulatory strength of the dopaminergic pathway on cognition in cocaine addiction. We used a sustained attention drug-word (DW) task that tests the processing of drug vs. matched neutral words . Using this DW task we showed that compared to controls cocaine addicts had higher drug-cue related activation in midbrain , and hypo-activation in anterior cingulate cortex . Based on our previous findings , – and preclinical studies documenting disruption of dopaminergic pathways with repeated cocaine administration , , we hypothesized that hypoactive brain regions in cocaine abusers would also show lower functional connectivity with midbrain.
Twenty healthy chronic cocaine abusers and 20 age-, gender-, and education-matched healthy control subjects participated in this study (Table 1). Participants were recruited from advertisements on public bulletin boards, in local newspapers, and by word-of-mouth. Eligible subjects were scheduled for an onsite evaluation that included a full physical and neurological examination by a neurologist. All subjects provided written informed consent as approved by the local Institutional Review Board (Stony Brook University's Committee on Research Involving Human Subjects, CORIHS), and were screened for absence of medical, psychiatric or neurological diseases. A clinical psychologist conducted a semi-structured diagnostic interview which included the Structured Clinical Interview for DSM-IV Axis I Disorders [research version , ] and the Addiction Severity Index .
Table 1. Subject characteristics.doi:10.1371/journal.pone.0010815.t001
Subjects were included in the study if they were (1) able to understand and give informed consent; and (2) had at least 12 years of education (or equivalent) and verbal intelligence ≥85 (estimated with the Wide Range Achievement Test reading subtest standard score). Subjects were excluded if they had: (3) history of head trauma or loss of consciousness (greater than 30 minutes) or other neurological disease of central origin (including seizures); (4) abnormal vital signs at time of screening or history of major medical conditions that may alter cerebral function, such as cardiovascular (including high blood pressure), endocrinological (including metabolic), oncological or autoimmune diseases for which the participant is required to take medications; (5) present or past history of psychiatric disorders other than substance abuse in cocaine abusers and nicotine dependence in all subjects; (6) positive urine screens for psychoactive drugs (or metabolites) other than cocaine (phencyclidine, benzodiazepines, cannabis, opiates, barbiturates and inhalants); (7) pregnancy, as confirmed with a urine test in all female subjects of childbearing age on study day; and (8) metal implants or other contraindications for MRI.
Differences in age, education, and verbal IQ between the groups were not statistically significant (p>0.07, two-sample t-test). Similarly, the gender difference between groups was not statistically significant (p = 0.27; Fisher's exact test). There were also no significant differences in symptoms of depression, as assessed with the Beck Depression Inventory II edition , between the cocaine and control groups (p = 0.093; two-sample t-test). Fifteen cocaine subjects were cigarette smokers while only five control subjects were cigarette smokers; the difference in cigarette smoking between the groups was statistically significant (p = 0.004; Fisher's exact test). Subjects were allowed to smoke regularly to minimize withdrawal symptoms. Specifically, seven cocaine subjects smoked within 4 hours prior the study and 4 additional cocaine subjects smoked within 6 hours prior the study. There was no difference in time since last cigarette (within 4 hours, >4 hrs, overnight or more) or in smoking frequency between the groups (P>0.54 t-test). Nineteen cocaine subjects met DSM-IV diagnosis for cocaine dependence or abuse, and had at least a 12-month (4 days/week for all but one subject) history of cocaine use (predominantly by the smoked route). Two cocaine dependent subjects also met diagnosis for cannabis or alcohol abuse. Two subjects had histories of past alcohol dependence. Seventeen of the cocaine subjects had a positive urine toxicology screen for cocaine on the day of the study, indicating that they used cocaine during the prior 72 hours. The urine toxicology screen was negative for the remaining three cocaine subjects and for all control subjects.
We used a drug-word (DW) paradigm that has been previously described . Briefly, 40 drug words matched on length, frequency in the English language, and part of speech (noun, adjective, adverb, verb) with 40 household-related (neutral) items were used (Fig. 1); non-English words or slang words that may have not been recognized by the control subjects were not included. These two word types (“Drug” and “Neutral”) were presented via MRI-compatible goggles in a blocked and counterbalanced fashion across subjects. Each of the 2 DW sequences (“drug” or “neutral”) had two 70-seconds long task epochs that included 20 trials. Each trial comprised a 500 ms fixation cross, a 2000 ms word presentation window, a 500 ms response window, and a 500 ms feedback where “O” and “X” were displayed for correct and incorrect trials, respectively. The words were presented using one of four possible colors (yellow, blue, red, green) and the word color order was pseudo randomized. Subjects were instructed to press one of four buttons (yellow, blue, red, green) of the MRI-compatible Lumina LP-400 response pad (Cedrus Corp., San Pedro, CA) during the response window matching the color of the word. A fixation cross against a black background was presented during the three 20-seconds long resting baseline epochs and subjects were instructed to not press any button and rest motionless as possible during these epochs. Thus, each sequence (“drug” or “neutral”) was 206 seconds long. The task was developed in E-prime (Psychology Software Tools, Inc., Pittsburgh, PA) and used a trigger pulse from the MRI console for precise synchronization with fMRI acquisition.
Figure 1. Drug-word fMRI paradigm.doi:10.1371/journal.pone.0010815.g001
A 4-Tesla whole-body Varian/Siemens MRI scanner and a T2*-weighted single-shot gradient-echo planar imaging (EPI) pulse sequence (TE/TR = 20/1600 ms, 4-mm slice thickness, 33 coronal slices, 64×64 matrix size, 3.1×3.1 mm in-plane resolution, 90°-flip angle, 131 time points) were used to map the blood oxygenation level dependent (BOLD) fMRI responses in the whole brain. Padding was used to minimize motion. Subject motion was monitored immediately after each fMRI run using a k-space motion detection algorithm  written in IDL (ITT Visual Information Solutions, Boulder, CO). Earplugs (acoustic noise attenuation: 28 dB; Aearo Ear TaperFit 2; Aearo Company) and headphones (acoustic noise attenuation: 30 dB; Commander XG MRI Audio System, Resonance Technology inc.) were used to minimize the interference effect of scanner noise during fMRI .
Anatomical images were collected using a T1-weighted 3D-MDEFT sequence  (TE/TR = 7/15 ms, 0.94×0.94×1.00 mm3 spatial resolution, axial orientation, 256 readout and 192×96 phase-encoding steps, 16 minutes scan time) and a modified T2-weigthed Hyperecho sequence  (TE/TR = 42/10000 ms, echo train length = 16, 256×256 matrix size, 30 coronal slices, 0.86×0.86 mm2 in-plane resolution, 5-mm thickness, no gap, 2 min scan time), and reviewed to rule out gross brain morphological abnormalities.
Image reconstruction was performed using an iterative phase correction method in IDL that minimizes signal-loss artifacts in EPI . The first four volumes in the time series were discarded to avoid non-equilibrium effects in the fMRI signal. Subsequent analyses were performed with the statistical parametric mapping package SPM2 (Welcome Department of Cognitive Neurology, London UK). The images were motion corrected with a 12-parameter affine transformation, spatially normalized to the standard brain (using a 12-parameters affine transformation with medium regularization and 16-nonlinear iterations and voxel size of 3×3×3 mm3), and smoothed (8-mm full-width-half-maximum Gaussian kernel). Note that spatial normalization to the stereotactic space was carried out using the standard SPM2 EPI template.
The general linear model used to calculate the individual BOLD contrast maps (drug epochs and neutral epochs) for each fMRI time series consisted of a box-car design convolved with the canonical hemodynamic response function (HRF) and a high-pass filter (cut-off frequency: 1/520 Hz). The BOLD signal strength was estimated without the removal of global effects (global normalization) to minimize false deactivation signals , . The estimated BOLD maps, contrasting word epochs (drug or neutral) against baseline epochs, were included in a two-way (word type × group) repeated measures analysis of variance (ANOVA) model in SPM2. Four covariates (smoking status, urine results, gender, and age) were included in this random-effects model in an effort to control for potential confounds. Brain activation clusters were corrected for multiple comparisons using the continuous random field calculation implemented in SPM2. Clusters with at least 15 voxels (400 mm3) and pcorr <0.05, corrected for multiple comparisons at the cluster level, were considered significant in group analyses of brain activation.
A method recently proposed for studies based on blocked fMRI datasets  was used to evaluate the functional connectivity of the brain using the resting epochs. Here, we were interested in the functional connectivity of the midbrain during the performance of the sustained attention condition of the drug-word task, not during resting-conditions. The task design was advantageous for this purpose because the “word” epochs were 70 seconds long, almost double the length of the resting blocks used by Fair and colleagues. In order to minimize unwanted task-related effects on the strength of correlations with midbrain (CM) we discarded 11 seconds from each word epoch, using the canonic hemodynamic response function to optimally select time points of the word epochs. Specifically, for each time series, the plateaus of the SPM2 canonic hemodynamic response function (Fig. 2A, red curve) were used to identify the 37 consecutive time points of the plateaus (Fig. 2B green and blue curves) corresponding to “word” epochs. This procedure accounted for the initial delay of the hemodynamic response and its return to baseline. The selected time points corresponding to each word epoch were concatenated to form “word” (“Drug” or “Neutral”) time series with 74 time points. “Word” time series were carefully inspected to ensure minimal baseline differences at the concatenation time points, and band-pass filtered (0.01–0.1 Hz; Fig. 2B, red curve), a step that further minimizes this baseline differences. A midbrain region (left substantia nigra, SN; talairach position: xyz = [−6, −15, −18] mm; Fig. 2C, green circle) that showed higher drug-cue related activation for cocaine addicts than for controls using a more complex version of the DW task  was selected as the “seed” voxel for the functional connectivity analysis. Whole-brain maps reflecting correlations between BOLD signals in the seed and those in all other voxels in the brain were calculated separately for each “word” time series. The Fisher transform was used to convert the step distributed Pearson linear correlation factors into normally distributed CM coefficients. These normalized CM maps (Fig. 2D) were computed and saved in Analyze format using IDL, and loaded into SPM2 for group analyses of CM . A two-way (word type × group) repeated measures ANOVA (random-effects) model with four covariates (smoking status, urine results, gender, and age) was used for group analyses of CM. Clusters with at least 15 voxels and pcorr <0.05 (corrected for multiple comparisons) were considered significant in group analysis of CM signals.
Figure 2. Functional connectivity analysis of task-related signal fluctuations during the blocked fMRI paradigm.
A: BOLD response elicited by the drug-word paradigm (black curve) and the fitted SPM2 canonic hemodynamic response (red curve). The gray periods identify the plateaus of the model. B: “Word” time series are composed by 37 the time points of plateau 1 (green curve) and the 37 time points of plateau 2 (blue curve). C: Mid-sagittal slice of an MRI structure showing the position of the midbrain seed used for the functional connectivity analysis. D: Mid-saggital slice exemplifying the normalized (z-score) maps reflecting correlations of MRI signals in the brain with those in midbrain. These individual maps were used in group analyses of functional connectivity.doi:10.1371/journal.pone.0010815.g002
Regions-of-interest (ROI) analyses
The relevant clusters were further evaluated with region-of-interest (ROI) analyses to identify potential outliers that might influence statistical analyses, and to report average values in a volume comparable to the image smoothness (e.g. resolution elements, or “resels” ) rather than single-voxel peak values. The volume of the resels was estimated using the random field calculation in SPM2 as a near cubic volume with Cartesian full-width-half-maximum (FWHM) of [13.0, 12.3, 13.4] mm for group analyses of brain activation and of [11.8, 11.0, 12.4] mm for group analyses of CM. Note that (2n+1)3 voxels fit into ROI that are symmetric around a peak voxel and that 3-mm isotropic voxels were used. We did not use n = 0 ROIs because do not take full advantage of the 13-mm isotropic resels (include only one voxel). Similarly, n = 2 ROIs were not used because they include voxels that do not belong to the average functional cluster defined by the resels. Thus, n = 1 ROIs were used to maximize the number of voxels within the smoothness of the data. Thus, the average BOLD and CM signals in the left and right medial dorsal nuclei of the thalamus (MDTHA; xyz = ±3, −15, 9 mm), cerebellum (CER; culmen; xyz = ±3, −45, −6 mm), and the rostral anterior cingulate cortex (rACC; xyz = ±3, 42, −3 mm) were extracted from the individual BOLD and CM maps in 9×9×9 mm3 ROI volumes containing 27 voxels to using IDL. We selected these ROIs based on our previous fMRI studies –, . These ROI masks were created and centered at the precise coordinates listed in Table 2; the coordinates of the ROI masks were kept fixed across subjects and conditions. Note that compared to variable-volume ROIs, fixed-volume (shape and size) ROIs are advantageous in order to minimize statistical confounds. Brain regions were labeled using the Talairach daemon (http://www.talairach.org/)  and a query range of 5 mm.
Differences in performance (accuracy and reaction time, RT) during the DW task were not statistically significant, either between groups (cocaine subjects vs. controls; accuracy: p = 0.55, F = 0.36, DF = 1; RT: p = 0.18, F = 1.89, DF = 1; repeated measures ANOVA) or between words (“Neutral” vs. “Drug”; accuracy: p = 0.64, F = 0.22, DF = 1; RT: p = 0.39, F = 0.77, DF = 1, Fig. 3). Similarly, group × word interaction effects on behavioral responses were not statistically significant (accuracy: p = 0.93, F = 0.009, DF = 1; RT: p = 0.66, F = 0.19, DF = 1).
Figure 3. Behavioral data.
Average performance accuracy (A) and reaction times (RT; B) during the drug-word (DW) paradigm for cocaine (N = 20) and control (N = 20) subjects.doi:10.1371/journal.pone.0010815.g003
In both groups, the DW paradigm activated a bilateral network that included the prefrontal cortex (PFC) [caudal dorsal anterior cingulate Brodmann area (BA) 32, inferior (BA 47), and middle (MFG; BA 9) frontal gyri], inferior (BA 40) and superior (BA 7) parietal cortices, thalamus, dorsal striatum, midbrain, and cerebellum and deactivated the parahippocampal (BA 30) and rostral anterior cingulate (rACC, BA 32) gyri, precuneus (BA 31), amygdala, and insula (BA 13) (pcorr <0.001, cluster-level corrected for multiple comparisons; Fig. 4 and Table 2). Group comparisons showed that activation was higher for controls than for cocaine abusers in the dorsolateral PFC (MFG BA 9, and precentral gyrus BA 6), cerebellum, thalamus, and left caudate (pcorr <0.05; Fig. 5A and Table 2); cocaine abusers deactivated more the rACC than controls (pcorr <0.05; Fig. 5A and Table 2). There were no statistically significant word-related differences (“Drug” > “Neutral” or “Neutral” > “Drug”) on brain activation. There were no statistically significant word × group interaction effects on brain activation.
Figure 4. Brain activation.
Statistical maps of BOLD-fMRI signals during the DW task across word conditions (“Drug” and “Neutral”) for 20 cocaine abusers (left) and 20 healthy matched control subjects (right). Random-effects analyses (two-way repeated measures ANOVA). Red-yellow and blue-green color bars show the t-score windows for activation and deactivation, respectively.doi:10.1371/journal.pone.0010815.g004
Figure 5. Brain activation and functional connectivity of midbrain.
A: Statistical map of BOLD-fMRI signals during the DW task across word conditions (conjunctive analysis “Drug” + “Neutral” vs. resting baseline) for controls > cocaine, superimposed on a sagittal view of the human brain. The light-blue squares and labels mark the positions of relevant ROI. The left side bar plots display the average BOLD responses in these regions for the cocaine and control groups (P<0.05). 5B: Statistical map of correlations with midbrain (CM) across word conditions (conjunctive analysis “Drug” + “Neutral” vs. resting baseline) for controls > cocaine, superimposed on a sagittal view of the human brain. The right side bar plots display the average CM signals in these regions for the cocaine and control groups (P<0.05). SPM Model: two-way repeated measures ANOVA. Sample: cocaine (N = 20) and control (N = 20) subjects. MDTHA: medial dorsal nucleus of the thalamus; CER: cerebellum (culmen); rACC: rostral anterior cingulate cortex (BA 32). ROI volume = 27 voxels (0.73 cc). Error bars are standard errors. CER: cerebellum; MDTHA: medial dorsal nucleus of the thalamus; rACC: rostral Anterior cingulate cortex.doi:10.1371/journal.pone.0010815.g005
Across subjects, bilateral occipital (BAs 17-19 and 37), temporal (BA 21), and cingulate (BAs 24, 30) cortex, ventral precuneus (BA 7), thalamus, parahippocampus, amygdala, putamen, caudate, cerebellum, and pons had positive CM (pcorr <0.001; Fig. 6); temporal (BAs 20, 22), parietal (BAs 2, 3, and 5), prefrontal (BA 9), cingulate (BA 32), and orbitofrontal (BAs 11 and 47) cortex, and posterior insula had negative CM (pcorr <0.001; Fig. 6). The CM in MDTHA, cerebellum and rACC was higher for controls than for cocaine abusers (pcorr <0.05; Fig. 5B). There were no statistically significant word-related differences in whole-brain analyses of CM.
Figure 6. Functional connectivity of midbrain.
Statistical maps of normalized CM coefficients during task epochs of the DW task across word conditions (“Drug” and “Neutral”) for 20 cocaine abusers (left) and 20 healthy matched control subjects (right). Random-effects analyses (two-way repeated measures ANOVA). Red-yellow and blue-green color bars show the t-score windows.doi:10.1371/journal.pone.0010815.g006
CM and BOLD signals in the thalamus were significantly correlated for control subjects (R = 0.61; P = 0.003; Fig. 7A) but not for cocaine subjects. CM signals in the thalamus were correlated negatively with the number of years of cocaine use in the cocaine subjects (R = −0.64; P = 0.002; Fig. 7B). BOLD and CM signals in CER and MDTHA did not show statistically significant correlations with self-reported time since last use of cocaine. However, CM (but not BOLD) signals in rACC were significantly correlated with self-reported time since last use of cocaine (Pc = 0.008, Bonferroni corrected for multiple comparisons; Z = 2.8).
Figure 7. Midbrain-thalamus functional connectivity of vs. thalamic activation and cocaine exposure.
Scatter plots of average CM coefficients vs. the average BOLD responses (A) and the duration of cocaine use in the life span (B) for the dorsal medial nucleus of the thalamus. Solid circles: cocaine addicts; open circles: controls. Solid and dashed lines are the corresponding linear fits. ROI volume = 27 voxels (0.73 cc). Error bars are standard errors. MDTHA: medial dorsal nucleus of the thalamus.doi:10.1371/journal.pone.0010815.g007
Here we show that the midbrain's positive functional connectivity with MDTHA, cerebellum (culmen), and rACC was significantly lower for cocaine subjects than for controls. In parallel and in absence of performance differences, cocaine subjects had lower activation in MDTHA and cerebellum and higher deactivation in rACC than controls, which is consistent with our previous findings in cocaine subjects tested with working memory  and visual attention tasks .
Using the DW task we recently showed that drug words, but not neutral words, activated the midbrain in cocaine subjects but not in controls . In the current work we evaluated the functional connectivity of this midbrain region (Talairach coordinates xyz = [−6, −15, −18] mm) with the rest of the brain using a different sample and a simplified version of the stimulation paradigm. Since the midbrain is relatively small and the imaging smoothing was larger than 12-mm is all directions, the functional responses in the selected seed region are representative of those in the entire midbrain. The midbrain (mesencephalon) is the origin of the main dopamine (DA) projections to the forebrain, and cocaine addicts have lower dopaminergic function than controls . Since cocaine binds to norepinephrine (NE) and DA transporters , thereby increasing extracellular NE and DA , , , chronic cocaine exposure could be additionally associated with disrupted neurotransmission in noradrenergic pathways including those into the thalamus. Indeed recent imaging studies have provided evidence of noradrenergic abnormalities in the thalamus (including medial dorsal nuclei) of cocaine abusers when compared with controls . Because midbrain also includes the upper portion of the locus coeruleus, the main norepinephrinergic nucleus in the brain, and the upper part of the rostral raphe, which is the main source of serotonergic innervation to cerebellum and forebrain, and considering that the spatial resolution of fMRI is limited to few mm , altered functional connectivity of the midbrain with MDTHA, cerebellum, and rACC could reflect not just neuroadaptations in dopaminergic but also in norepinephrinergic and/or serotonergic neurotransmission with chronic cocaine exposure.
The MDTHA had lower CM and lower BOLD signals for cocaine abusers than for control subjects. These results are consistent with previous studies that documented reduced DA release  and reduced activation , ,  in the MDTHA for cocaine abusers compared to control subjects. The MDTHA is innervated by norepinephrinergic and dopaminergic neurons . Our current findings may therefore reflect a dysfunctional norepinephrinergic and dopaminergic regulation of the MDTHA in cocaine addicts. This interpretation is further supported by the negative correlation between the thalamic CM signals and the years of cocaine use, which suggests that functional connectivity could be a better marker than BOLD responses for the precise characterization of drug-related neuroadaptations. The positive correlation of thalamic BOLD and CM signals in control subjects and the lack of similar correlations in cocaine subjects further supports this conclusion.
This study also shows an association between hypo-activation and lower CM in the cerebellum for cocaine subjects compared to controls. The locus coeruleus, a homeostatic gray matter nucleus in the brainstem (lower midbrain/pons), is the main source of norepinephrinergic innervation to the thalamus and cerebellum  and is closely located to our midbrain seed (22 mm; 7 imaging voxels apart from midbrain; Fig. 7). These results are therefore consistent with altered norepinephrinergic regulation in cocaine addiction. Since most cocaine subjects had a positive urine for cocaine on the day of the study, the cocaine subjects' lower cerebellar BOLD and CM signals may reflect in part activation of norepinephrinergic pathways during short-term/acute withdrawal . However, it could also reflect serotonergic dysfunction since there is increasing evidence of serotonergic regulation of cerebellar activity .
The negative BOLD responses in the rACC were higher and the CM signals in rACC were lower for cocaine abusers than for control subjects. The rACC, which is innervated by DA, noradrenergic  and serotonergic  neurons has been implicated in generation or regulation of spontaneous internal thoughts, emotions, anxiety and in internal conflict resolution –. Indeed, the rACC activates during emotional tasks and deactivates during cognitive tasks , . Taking into account that compared to controls cocaine subjects showed rACC hypoactivation during this  and other , ,  fMRI paradigms, the higher negative BOLD responses and the lower CM signals in rACC may reflect lower DA-mediated suppression of task-irrelevant emotional responses during fMRI in cocaine abusers.
We did not exclude smokers as from our experience around 75% of cocaine subjects smoke cigarettes (vs. around 25% of controls). Fifteen cocaine subjects and five control subjects were smokers, and the group difference was statistically significant. Subjects were allowed to smoke regularly to minimize withdrawal symptoms. Previous studies have shown that nicotine can induce a dose-dependent increase in neuronal activity in a distributed system of brain regions, including the nucleus accumbens, amygdala, cingulate, and frontal lobes . Therefore, the blunted responses of the cocaine smokers could have been even more suppressed if they would have been abstinent for nicotine prior the study. Taking into account that the average elimination half-life for plasma nicotine is 2 hours in humans , and given that none of the controls subjects and only two cocaine subjects smoked within the 2-hours period before the study, none of them smoked during the study, and there was no difference between groups in time since last cigarette, the potentially circulating nicotine levels should have been low and the differential effects of nicotine on brain activation should be minimal. Note that contrasting with our previous study , we did not observe drug vs. neutral word activation differences in midbrain in the present study, probably reflecting the lack of monetary incentive conditions and the lower statistical power associated to the simplified version of the DW paradigm.
Summary: Using high-field (4 Tesla) fMRI, here we show that during processing of drug and matched neutral words cocaine abusers have similar accuracy and reaction times to matched controls, but lower BOLD and CM signals in the dorsal medial nucleus of the thalamus, cerebellum, and rostral anterior cingulate cortex. These findings suggest that lower recruitment of subcortical resources and impaired inhibition of cortical resources may be mediated by abnormal functional connectivity of catecholamine (dopamine, norepinephrine and serotonin) pathways in cocaine abusers. The negative correlation of the thalamic CM (and the lack of correlation with BOLD responses in the thalamus) with years of cocaine use suggests that functional connectivity might be more sensitive than standard fMRI activation techniques for the detection of subtle functional neuroadaptations associated with drug addiction.
Conceived and designed the experiments: DT NDV RZG. Performed the experiments: DT RW TM NAK PAW FT RZG. Analyzed the data: DT JFH RZG. Contributed reagents/materials/analysis tools: DT. Wrote the paper: DT NDV RZG.
- 1. Beveridge T, Smith H, Nader M, Porrino L (2005) Effects of chronic cocaine self-administration on norepinephrine transporters in the nonhuman primate brain. Psychopharmacology (Berl) 180: 781–788.
- 2. Volkow N, Fowler J, Wang G, Swanson J, Telang F (2007) Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 64: 1575–1579.
- 3. Borgland S, Taha S, Sarti F, Fields H, Bonci A (2006) Orexin A in the VTA Is Critical for the Induction of Synaptic Plasticity and Behavioral Sensitization to Cocaine. Neuron 49: 589–601.
- 4. Cunningham K, Paris J, Goeders N (1992) Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding. Synapse 11: 112–123.
- 5. Volkow N, Wang G, Fowler J, Logan J, Gatley S, et al. (1997) Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830–833.
- 6. Goldstein R, Leskovjan A, Hoff A, Hitzemann R, Bashan F, et al. (2004) Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia 42: 1447–1458.
- 7. Aharonovich E, Nunes E, Hasin D (2003) Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend 71: 207–211.
- 8. Garavan H, Kaufman J, Hester R (2008) Acute effects of cocaine on the neurobiology of cognitive control. Philos Trans R Soc Lond B Biol Sci 363: 3267–3276.
- 9. Hester R, Garavan H (2004) Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci 24: 11017–11022.
- 10. Buzsaki G, Draguhn A (2004) Neuronal oscillations in cortical networks. Science 304: 1926–1929.
- 11. Buxton RBIntroduction to Functional Magnetic Resonance Imaging: Principles and Techniques. 2002: Cambridge University Press.
- 12. Biswal B, Yetkin F, Haughton V, Hyde J (1995) Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 34: 537–541.
- 13. Fox M, Raichle M (2007) Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 8: 700–711.
- 14. Goldstein R, Tomasi D, Rajaram S, Cottone L, Zhang L, et al. (2007) Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience 144: 1153–1159.
- 15. Goldstein R, Tomasi D, Alia-Klein N, Carrillo J, Maloney T, et al. (2009) Dopaminergic response to drug words in cocaine addiction. J Neurosci 29: 6001–6006.
- 16. Goldstein R, Alia-Klein N, Tomasi D, Carrillo J, Maloney T, et al. (2009) Anterior cingulate cortex hypoactivations to an emotionally salient task in cocaine addiction. Proc Natl Acad Sci U S A 106: 9453–9458.
- 17. Tomasi D, Goldstein R, Telang F, Maloney T, Alia-Klein N, et al. (2007) Thalamo-cortical dysfunction in cocaine abusers: implications in attention and perception. Psych Res Neuroimaging 155: 189–201.
- 18. Tomasi D, Goldstein R, Telang F, Maloney T, Alia-Klein N, et al. (2007) Cocaine abusers have widespread disruption in brain activation patterns to a working memory task. Brain Res 1171: 83–92.
- 19. Grace A, Floresco S, Goto Y, Lodge D (2007) Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30: 220–227.
- 20. Calabresi P, Picconi B, Tozzi A, Di Filippo M (2007) Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 30: 1614–1620.
- 21. First M, RL S, Gibbon M, Williams J (1996) Structured Clinical Interview for DSM-IV Axis I disorders -Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute.
- 22. Ventura J, Liberman RP, Green MF, Shaner A, Mintz J (1998) Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res 79: 163–173.
- 23. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, et al. (1992) The fifth edition of the addiction severity index. J Subst Abuse Treat 9: 199–213.
- 24. Beck A, Steer R, Brown GBeck Depression Inventory Manual. 2nd ed ed. San Antonio: The Psychological Corporation. 1996.
- 25. Caparelli EC, Tomasi D, Arnold S, Chang L, Ernst T (2003) k-Space based summary motion detection for functional magnetic resonance imaging. NeuroImage 20: 1411–1418.
- 26. Tomasi D, Caparelli EC, Chang L, Ernst T (2005) fMRI-acoustic noise alters brain activation during working memory tasks. Neuroimage 27: 377–386.
- 27. Lee JH, Garwood M, Menon R, Adriany G, Andersen P, et al. (1995) High contrast and fast three-dimensional magnetic resonance imaging at high fields. Magn Reson Med 34: 308–312.
- 28. Hennig J, Scheffler K (2001) Hyperechoes. Magn Reson Med 46: 6–12.
- 29. Caparelli E, Tomasi D (2008) K-space spatial low-pass filters can increase signal loss artifacts in Echo-Planar Imaging. Biomed Signal Process Control 3: 107–114.
- 30. Aguirre GK, Zarahn E, D'Esposito M (1998) The inferential impact of global signal covariates in functional neuroimaging analyses. Neuroimage 8: 302–306.
- 31. Gavrilescu M, Shaw ME, Stuart GW, Eckersley P, Svalbe ID, et al. (2002) Simulation of the effects of global normalization procedures in Functional MRI. Neuroimage 17: 532–542.
- 32. Fair D, Schlaggar B, Cohen A, Miezin F, Dosenbach N, et al. (2007) A method for using blocked and event-related fMRI data to study “resting state” functional connectivity. Neuroimage 35: 396–405.
- 33. Tomasi D, Wang R, Telang F, Boronikolas V, Jayne M, et al. (2009) Impairment of Attentional Networks after 1 Night of Sleep Deprivation. Cereb Cortex 19: 233–240.
- 34. Worsley K, Evans A, Marrett S, Neelin P (1992) A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 12: 900–918.
- 35. Goldstein R, Tomasi D, Alia-Klein N, Zhang L, Telang F, et al. (2007) The effect of practice on a sustained attention task in cocaine abusers. Neuroimage 35: 194–206.
- 36. Lancaster J, Woldorff M, Parsons L, Liotti M, Freitas C, et al. (2000) Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10: 120–131.
- 37. Raiteri M, Del Carmine R, Bertollini A, Levi G (1977) Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol 41: 133–143.
- 38. Ritz M, Lamb R, Goldberg S, Kuhar M (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219–1223.
- 39. Tanda G, Pontieri F, Frau R, Di Chiara G (1997) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9: 2077–2085.
- 40. Ding Y, Singhal T, Planeta-Wilson B, Gallezot J, Nabulsi N, et al. (2010) PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT. Synapse 64: 30–38.
- 41. Tomasi D, Caparelli E (2007) Macrovascular contribution in activation patterns of working memory. J Cereb Blood Flow Metab 27: 33–42.
- 42. Kubler A, Murphy K, Garavan H (2005) Cocaine dependence and attention switching within and between verbal and visuospatial working memory. Eur J Neurosci 21: 1984–1992.
- 43. Oke A, Solnick J, Adams R (1986) Catecholamine distribution patterns in rat thalamus. Brain Res 269: 180–183.
- 44. Rogawski M, Aghajanian G (1980) Modulation of lateral geniculate neurone excitability by noradrenaline microiontophoresis or locus coeruleus stimulation. Nature 287: 731–734.
- 45. Kelley B, Yeager K, Pepper T, Beversdorf D (2005) Cognitive impairment in acute cocaine withdrawal. Cogn Behav Neurol 18: 108–112.
- 46. Dieudonné S (2001) Serotonergic neuromodulation in the cerebellar cortex: cellular, synaptic, and molecular basis. Neuroscientist 7: 207–219.
- 47. Morrison J, Molliver M, Grzanna R, Coyle J (1979) Noradrenergic innervation patterns in three regions of medial cortex: an immunofluorescence characterization. Brain Res Bull 4: 849–857.
- 48. Olpe H, Koella W (2001) The cortical projection of the dorsal raphe nucleus: some electrophysiological and pharmacological properties. Brain Res 216: 61–71.
- 49. Mason M, Norton M, Van Horn J, Wegner D, Grafton S, et al. (2007) Wandering minds: the default network and stimulus-independent thought. Science 315: 393–395.
- 50. Simpson JR, Drevets WC, Snyder AZ, Gusnard DA, Raichle ME (2001) Emotion-induced changes in human medial prefrontal cortex: II. During anticipatory anxiety. Proc Natl Acad Sci USA 98: 688–693.
- 51. Simpson JR, Snyder AZ, Gusnard DA, Raichle ME (2001) Emotion-induced changes in human medial prefrontal cortex: I. During cognitive task performance. Proc Natl Acad Sci USA 98: 683–687.
- 52. Horovitz S, Braun A, Carr W, Picchioni D, Balkin T, et al. (2009) Decoupling of the brain's default mode network during deep sleep. Proc Natl Acad Sci U S A 106: 11376–11381.
- 53. Bush G, Shin L, Holmes J, Rosen B, Vogt B (2003) The Multi-Source Interference Task: validation study with fMRI in individual subjects. Mol Psychiatry 8: 60–70.
- 54. Tomasi D, Ernst T, Caparelli EC, Chang L (2006) Common deactivation patterns during working memory and visual attention tasks: An intra-subject fMRI study at 4 Tesla. Hum Brain Mapp 27: 694–705.
- 55. Li C, Huang C, Yan P, Bhagwagar Z, Milivojevic V, et al. (2008) Neural correlates of impulse control during stop signal inhibition in cocaine-dependent men. Neuropsychopharmacology 33: 1798–1806.
- 56. Stein EA, Pankiewicz J, Harsch HH, Cho JK, Fuller SA, et al. (1998) Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. 155: 1009–1015.
- 57. Matta S, Balfour D, Benowitz N, Boyd R, Buccafusco J, et al. (2007) Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190: 269–319.